RE: Cambridge study - antibody tests for diagnosis4 Sep 2020 10:28
I posted this last night.... Beckman Coulter said the same thing.
BC are a massive US diagnostics company. Waaay bigger than ALL of our AIM UK Covid minnows. Their research is similar to the guardian article published for the way Addenbrokes do their covid testing combining both antibody and antigen.
https://www.prnewswire.com/news-releases/beckman-coulter-launches-sars-cov-2-igm-antibody-test-and-will-begin-shipping-to-us-diagnostics-labs-301116845.html
Shamiram Feinglass, M.D., MPH, chief medical officer for Beckman Coulter, added, "At a time when a number of regions around the country are experiencing long wait times for testing due to shortages of molecular diagnostics (RT-PCR testing), antibody testing may play a key role in helping physicians determine if their patients have had a recent infection. Recent studies have identified asymptomatic individuals with a negative PCR test and a positive IgM test1 suggesting these patients may have had a low viral load or provided inadequate PCR samples. A positive IgM antibody test may help physicians identify some of these patients who received a false negative PCR result and should self-isolate until a follow up PCR test can be administered."
It has recently been reported that there are a number of states experiencing shortages of molecular diagnostics for the novel coronavirus, as well as backlogs on their analyzers due to high demand as infection rates surge. The Access SARS-CoV-2 IgM assay can help to alleviate this issue, as it helps to identify patients with an immune response to SARS-CoV-2.
The above paragraph is detailing the exact issue we are facing in the UK, and come winter surely they must utilise antibody tests to check for Covid. Especially as our test costs the government absolutely peanuts.